1. Home
  2. VVOS vs GDTC Comparison

VVOS vs GDTC Comparison

Compare VVOS & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • GDTC
  • Stock Information
  • Founded
  • VVOS 2016
  • GDTC 2018
  • Country
  • VVOS United States
  • GDTC Singapore
  • Employees
  • VVOS N/A
  • GDTC N/A
  • Industry
  • VVOS Medical Specialities
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • GDTC Health Care
  • Exchange
  • VVOS Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • VVOS 27.3M
  • GDTC 24.2M
  • IPO Year
  • VVOS 2020
  • GDTC 2023
  • Fundamental
  • Price
  • VVOS $2.89
  • GDTC $2.25
  • Analyst Decision
  • VVOS Strong Buy
  • GDTC Buy
  • Analyst Count
  • VVOS 2
  • GDTC 1
  • Target Price
  • VVOS $6.25
  • GDTC $5.00
  • AVG Volume (30 Days)
  • VVOS 269.2K
  • GDTC 103.0K
  • Earning Date
  • VVOS 11-13-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • VVOS N/A
  • GDTC N/A
  • EPS Growth
  • VVOS N/A
  • GDTC N/A
  • EPS
  • VVOS N/A
  • GDTC N/A
  • Revenue
  • VVOS $14,393,000.00
  • GDTC $573,193.00
  • Revenue This Year
  • VVOS $16.05
  • GDTC $5.37
  • Revenue Next Year
  • VVOS $43.75
  • GDTC N/A
  • P/E Ratio
  • VVOS N/A
  • GDTC N/A
  • Revenue Growth
  • VVOS 2.65
  • GDTC 63.03
  • 52 Week Low
  • VVOS $1.98
  • GDTC $1.65
  • 52 Week High
  • VVOS $7.95
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 33.05
  • GDTC 60.01
  • Support Level
  • VVOS $3.02
  • GDTC $1.95
  • Resistance Level
  • VVOS $3.28
  • GDTC $2.43
  • Average True Range (ATR)
  • VVOS 0.24
  • GDTC 0.17
  • MACD
  • VVOS 0.02
  • GDTC 0.02
  • Stochastic Oscillator
  • VVOS 9.84
  • GDTC 65.54

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: